{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:12:06Z","timestamp":1790809926053,"version":"4.1.0"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p><jats:italic>LKB1<\/jats:italic> (liver kinase B1) is a master regulator of several processes such as metabolism, proliferation, cell polarity and immunity. About one third of non-small cell lung cancers (NSCLCs) present <jats:italic>LKB1<\/jats:italic> alterations, which almost invariably lead to protein loss, resulting in the absence of a potential druggable target. In addition, LKB1-null tumors are very aggressive and resistant to chemotherapy, targeted therapies and immune checkpoint inhibitors (ICIs). In this review, we report and comment strategies that exploit peculiar co-vulnerabilities to effectively treat this subgroup of NSCLCs. LKB1 loss leads to an enhanced metabolic avidity, and treatments inducing metabolic stress were successful in inhibiting tumor growth in several preclinical models. Biguanides, by compromising mitochondria and reducing systemic glucose availability, and the glutaminase inhibitor telaglenastat (CB-839), inhibiting glutamate production and reducing carbon intermediates essential for TCA cycle progression, have provided the most interesting results and entered different clinical trials enrolling also LKB1-null NSCLC patients. Nutrient deprivation has been investigated as an alternative therapeutic intervention, giving rise to interesting results exploitable to design specific dietetic regimens able to counteract cancer progression. Other strategies aimed at targeting LKB1-null NSCLCs exploit its pivotal role in modulating cell proliferation and cell invasion. Several inhibitors of LKB1 downstream proteins, such as mTOR, MEK, ERK and SRK\/FAK, resulted specifically active on <jats:italic>LKB1<\/jats:italic>-mutated preclinical models and, being molecules already in clinical experimentation, could be soon proposed as a specific therapy for these patients. In particular, the rational use in combination of these inhibitors represents a very promising strategy to prevent the activation of collateral pathways and possibly avoid the potential emergence of resistance to these drugs. LKB1-null phenotype has been correlated to ICIs resistance but several studies have already proposed the mechanisms involved and potential interventions. Interestingly, emerging data highlighted that <jats:italic>LKB1<\/jats:italic> alterations represent positive determinants to the new KRAS specific inhibitors response in <jats:italic>KRAS<\/jats:italic> co-mutated NSCLCs. In conclusion, the absence of the target did not block the development of treatments able to hit <jats:italic>LKB1<\/jats:italic>-mutated NSCLCs acting on several fronts. This will give patients a concrete chance to finally benefit from an effective therapy.<\/jats:p>","DOI":"10.3389\/fonc.2022.889826","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:42:08Z","timestamp":1652290928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["LKB1: Can We Target an Hidden Target? Focus on NSCLC"],"prefix":"10.3389","volume":"12","author":[{"given":"Gloriana","family":"Ndembe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Intini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Marabese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Caiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mendogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","article-title":"Inactivation of LKB1\/STK11 Is a Common Event in Adenocarcinomas of the Lung","volume":"62","author":"Sanchez-Cespedes","year":"2002","journal-title":"Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0197-87","article-title":"Localization of a Susceptibility Locus for Peutz-Jeghers Syndrome to 19p Using Comparative Genomic Hybridization and Targeted Linkage Analysis","volume":"15","author":"Hemminki","year":"1997","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00642-2","article-title":"LKB1, a Protein Kinase Regulating Cell Proliferation and Polarity","volume":"546","author":"Boudeau","year":"2003","journal-title":"FEBS Lett"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2016.710071","article-title":"LKB1, A New Biomarker in Breast Cancer","volume":"7","author":"Lattouf","year":"2016","journal-title":"JCT"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/34432","article-title":"A Serine\/Threonine Kinase Gene Defective in Peutz\u2013Jeghers Syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nat"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.10.791","article-title":"An Investigation of the Peutz-Jeghers Gene (LKB1) in Sporadic Breast and Colon Cancers","volume":"53","author":"Forster","year":"2000","journal-title":"J Clin Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"110872","DOI":"10.1016\/j.biopha.2020.110872","article-title":"LKB1 and Cancer: The Dual Role of Metabolic Regulation","volume":"132","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature06030","article-title":"LKB1 Modulates Lung Cancer Differentiation and Metastasis","volume":"448","author":"Ji","year":"2007","journal-title":"Nat"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210594","article-title":"A Role for LKB1 Gene in Human Cancer Beyond the Peutz\u2013Jeghers Syndrome","volume":"26","author":"Sanchez-Cespedes","year":"2007","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature20132","article-title":"LKB1 Loss Links Serine Metabolism to DNA Methylation and Tumorigenesis","volume":"539","author":"Kottakis","year":"2016","journal-title":"Nat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91291","article-title":"Comparative Oncogenomics Identifies Tyrosine Kinase FES as a Tumor Suppressor in Melanoma","volume":"127","author":"Olvedy","year":"2017","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93597","article-title":"Stromal Lkb1 Deficiency Leads to Gastrointestinal Tumorigenesis Involving the IL-11\u2013JAK\/STAT3 Pathway","volume":"128","author":"Ollila","year":"2017","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.02.049","article-title":"KRAS-Mutant non-Small Cell Lung Cancer: Converging Small Molecules and Immune Checkpoint Inhibition","volume":"41","author":"Adderley","year":"2019","journal-title":"EBioMed"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210418","article-title":"Prevalence and Specificity of LKB1 Genetic Alterations in Lung Cancers","volume":"26","author":"Matsumoto","year":"2007","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65314-X","article-title":"LKB1 Somatic Mutations in Sporadic Tumors","volume":"154","author":"Avizienyte","year":"1999","journal-title":"Am J Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.13.3.601","article-title":"Mutations of the STK11 Gene in Sporadic Gastric Carcinoma","volume":"13","author":"Park","year":"1998","journal-title":"Int J Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.08.002","article-title":"LKB1\/STK11 Mutations in Non-Small Cell Lung Cancer Patients: Descriptive Analysis and Prognostic Value","volume":"112","author":"Facchinetti","year":"2017","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6877","article-title":"Molecular Mechanism of LKB1 in the Invasion and Metastasis of Colorectal Cancer","volume":"41","author":"Chen","year":"2018","journal-title":"Oncol Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1158\/1541-7786.MCR-19-0530","article-title":"AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis","volume":"18","author":"Buensuceso","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3112","article-title":"Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma","volume":"21","author":"Calles","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-Dependent Signaling Pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg490","article-title":"MO25 \/ Interact With STRAD \/ Enhancing Their Ability to Bind, Activate and Localize LKB1 in the Cytoplasm","volume":"22","author":"Boudeau","year":"2003","journal-title":"EMBO J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a Master Kinase That Activates 13 Kinases of the AMPK Subfamily, Including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308061100","article-title":"The Tumor Suppressor LKB1 Kinase Directly Activates AMP-Activated Kinase and Regulates Apoptosis in Response to Energy Stress","volume":"101","author":"Shaw","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1748-1716.2009.01972.x","article-title":"LKB1 and AMP-Activated Protein Kinase Control of mTOR Signalling and Growth","volume":"196","author":"Shaw","year":"2009","journal-title":"Acta Physiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CMAR.S282417","article-title":"Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway","volume":"13","author":"Wang","year":"2021","journal-title":"CMAR"},{"key":"B27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gendis.2014.06.002","article-title":"LKB1 Tumor Suppressor: Therapeutic Opportunities Knock When LKB1 is Inactivated","volume":"1","author":"Zhou","year":"2014","journal-title":"Genes Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature23665","article-title":"Homeostatic Control of Metabolic and Functional Fitness of Treg Cells by LKB1 Signalling","volume":"548","author":"Yang","year":"2017","journal-title":"Nat"},{"key":"B29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41422-019-0157-4","article-title":"LKB1 Orchestrates Dendritic Cell Metabolic Quiescence and Anti-Tumor Immunity","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.13.16244","article-title":"LKB1\/AMPK\/mTOR Signaling Pathway in Hematological Malignancies: From Metabolism to Cancer Cell Biology","volume":"10","author":"Green","year":"2011","journal-title":"Cell Cycle"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608531103","article-title":"AMP-Activated Protein Kinase Regulates the Assembly of Epithelial Tight Junctions","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610157104","article-title":"Regulation of Epithelial Tight Junction Assembly and Disassembly by AMP-Activated Protein Kinase","volume":"104","author":"Zheng","year":"2007","journal-title":"PNAS"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181fbc28a","article-title":"LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis","volume":"5","author":"Marcus","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2008.01.008","article-title":"LKB1 and AMPK in Cell Polarity and Division","volume":"18","author":"Williams","year":"2008","journal-title":"Trends Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4161\/cc.6.22.4927","article-title":"AMPK\/LKB1 Signaling in Epithelial Cell Polarity and Cell Division","volume":"6","author":"Brenman","year":"2007","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.127.7.1467","article-title":"The C. Elegans Par-4 Gene Encodes a Putative Serine-Threonine Kinase Required for Establishing Embryonic Asymmetry","volume":"127","author":"Watts","year":"2000","journal-title":"Development"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103473","article-title":"LKB1 Inactivation Leads to Centromere Defects and Genome Instability via P53-Dependent Upregulation of Survivin","volume":"12","author":"Jin","year":"2020","journal-title":"Aging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.125","article-title":"Possible Involvement of LKB1-AMPK Signaling in Non-Homologous End Joining","volume":"33","author":"Ui","year":"2014","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.315","article-title":"LKB1 Reduces ROS-Mediated Cell Damage via Activation of P38","volume":"34","author":"Xu","year":"2015","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12334","article-title":"LKB1 is a DNA Damage Response Protein That Regulates Cellular Sensitivity to PARP Inhibitors","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412065200","article-title":"DNA Damage-Induced Association of ATM With its Target Proteins Requires a Protein Interaction Domain in the N Terminus of ATM","volume":"280","author":"Fernandes","year":"2005","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13238-011-1021-6","article-title":"LKB1 in Lung Cancerigenesis: A Serine\/Threonine Kinase as Tumor Suppressor","volume":"2","author":"Gao","year":"2011","journal-title":"Protein Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/cells10113129","article-title":"STK11\/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact","volume":"10","author":"Pons-Tostivint","year":"2021","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2105","article-title":"KEAP1-Driven Co-Mutations in Lung Adenocarcinoma Unresponsive to Immunotherapy Despite High Tumor Mutational Burden","volume":"31","author":"Marinelli","year":"2020","journal-title":"Ann Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1543","article-title":"Resistance to Durvalumab and Durvalumab Plus Tremelimumab Is Associated With Functional STK11 Mutations in Patients With Non\u2013Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown","volume":"11","author":"Pore","year":"2021","journal-title":"Cancer Discovery"},{"key":"B46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-Cell Activity in the Lung Tumor Microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/annonc\/mdw436","article-title":"Whole-Exome Sequencing and Immune Profiling of Early-Stage Lung Adenocarcinoma With Fully Annotated Clinical Follow-Up","volume":"28","author":"Kadara","year":"2017","journal-title":"Ann Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s42003-020-1092-0","article-title":"STK11 (LKB1) Missense Somatic Mutant Isoforms Promote Tumor Growth, Motility and Inflammation","volume":"3","author":"Granado-Mart\u00ednez","year":"2020","journal-title":"Commun Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.98","article-title":"Frequent Homozygous Deletion of the LKB1\/STK11 Gene in non-Small Cell Lung Cancer","volume":"30","author":"Gill","year":"2011","journal-title":"Oncogene"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discovery"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cells9102308","article-title":"Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/diagnostics11020196","article-title":"The Importance of STK11\/LKB1 Assessment in Non-Small Cell Lung Carcinomas","volume":"11","author":"Mograbi","year":"2021","journal-title":"Diagnostics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2676","article-title":"The LKB1\u2013AMPK Pathway: Metabolism and Growth Control in Tumour Suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymben.2016.12.010","article-title":"LKB1 Promotes Metabolic Flexibility in Response to Energy Stress","volume":"43","author":"Parker","year":"2017","journal-title":"Metab Engineering"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.140","article-title":"LKB1 Deficiency Enhances Sensitivity to Energetic Stress Induced by Erlotinib Treatment in non-Small-Cell Lung Cancer (NSCLC) Cells","volume":"35","author":"Whang","year":"2016","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209951","article-title":"Dysfunctional AMPK Activity, Signalling Through mTOR and Survival in Response to Energetic Stress in LKB1-Deficient Lung Cancer","volume":"26","author":"Carretero","year":"2007","journal-title":"Oncogene"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and Reduced Risk of Cancer in Diabetic Patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.05.023","article-title":"Metformin in Cancer","volume":"413","author":"Mallik","year":"2018","journal-title":"Diabetes Res Clin Practice"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014mode of Action and Clinical Implications for Diabetes and Cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-Dose Metformin Targets the Lysosomal AMPK Pathway Through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin","volume":"23","author":"Shackelford","year":"2013","journal-title":"Cancer Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.07.102","article-title":"Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-Mutated KRAS\/LKB1 NSCLC","volume":"13","author":"Moro","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.04.005","article-title":"LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress\u2013Based Treatments","volume":"16","author":"Borzi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312570111","article-title":"Loss of the Tumor Suppressor LKB1 Promotes Metabolic Reprogramming of Cancer Cells via HIF-1","volume":"111","author":"Faubert","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1177\/03008916211023548","article-title":"Multidimensional Mechanisms of Metformin in Cancer Treatment","volume":"108","author":"Singh-Makkar","year":"2021","journal-title":"Tumori"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0797","article-title":"Heightening Energetic Stress Selectively Targets LKB1-Deficient Non\u2013Small Cell Lung Cancers","volume":"75","author":"Momcilovic","year":"2015","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000875","article-title":"Metformin Mediated microRNA-7 Upregulation Inhibits Growth, Migration, and Invasion of non-Small Cell Lung Cancer A549 Cells","volume":"31","author":"Dong","year":"2020","journal-title":"Anti-Cancer Drugs"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28470","article-title":"Metformin Promotes Survivin Degradation Through AMPK\/PKA\/GSK-3\u03b2-Axis in non\u2013Small Cell Lung Cancer","volume":"120","author":"Luo","year":"2019","journal-title":"J Cell Biochem"},{"key":"B71","article-title":"IAP-Family Protein Survivin Inhibits Caspase Activity and Apoptosis Induced by Fas (CD95), Bax, Caspases, and Anticancer Drugs","volume":"58","author":"Tamm","year":"1998","journal-title":"Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0375","article-title":"Survivin, a Cancer Target With an Emerging Role in Normal Adult Tissues","volume":"5","author":"Fukuda","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-1072","article-title":"Metformin Reverses Chemoresistance in non-Small Cell Lung Cancer via Accelerating Ubiquitination-Mediated Degradation of Nrf2","volume":"9","author":"Huang","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00191","article-title":"Metformin and Its Benefits for Various Diseases","volume":"11","author":"Lv","year":"2020","journal-title":"Front Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the Benefit of Metformin Use in Cancer Treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8730816","article-title":"LKB1\/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective","volume":"2019","author":"Ciccarese","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.12.011","article-title":"Exploiting FAsting-Mimicking Diet and MEtformin to Improve the Efficacy of Platinum-Pemetrexed Chemotherapy in Advanced LKB1-Inactivated Lung Adenocarcinoma: The FAME Trial","volume":"20","author":"Vernieri","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-018-0954-5","article-title":"Co-Occurring KRAS Mutation\/LKB1 Loss in non-Small Cell Lung Cancer Cells Results in Enhanced Metabolic Activity Susceptible to Caloric Restriction: An In Vitro Integrated Multilevel Approach","volume":"37","author":"Caiola","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.10.037","article-title":"A Review of Fasting Effects on the Response of Cancer to Chemotherapy","volume":"40","author":"Sadeghian","year":"2021","journal-title":"Clin Nutr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau2095","article-title":"A Time to Fast","volume":"362","author":"Di Francesco","year":"2018","journal-title":"Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: Molecular Mechanisms and Clinical Applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","article-title":"A Periodic Diet That Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan","volume":"22","author":"Brandhorst","year":"2015","journal-title":"Cell Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1770849","article-title":"Unravelling the Health Effects of Fasting: A Long Road From Obesity Treatment to Healthy Life Span Increase and Improved Cognition","volume":"52","author":"Wilhelmi de Toledo","year":"2020","journal-title":"Ann Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2016.00142\/abstract","article-title":"Better Living Through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan","volume":"7","author":"Gillespie","year":"2016","journal-title":"Front Genet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003293","article-title":"Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy","volume":"4","author":"Lee","year":"2012","journal-title":"Sci Transl Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708100105","article-title":"Starvation-Dependent Differential Stress Resistance Protects Normal But Not Cancer Cells Against High-Dose Chemotherapy","volume":"105","author":"Raffaghello","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0061-0","article-title":"Fasting and Cancer: Molecular Mechanisms and Clinical Application","volume":"18","author":"Nencioni","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav2588","article-title":"Glutamine Blockade Induces Divergent Metabolic Programs to Overcome Tumor Immune Evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.589508","article-title":"Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ccr.2010.08.017","article-title":"Cancer Metabolism: Is Glutamine Sweeter Than Glucose","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0902","article-title":"Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer","volume":"7","author":"Wu","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131859","article-title":"Targeting Glutamine Metabolism Enhances Tumor-Specific Immunity by Modulating Suppressive Myeloid Cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab"},{"key":"B95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-015-0137-1","article-title":"Targeting Glutamine Metabolism Sensitizes Pancreatic Cancer to PARP-Driven Metabolic Catastrophe Induced by \u00df-Lapachone","volume":"3","author":"Chakrabarti","year":"2015","journal-title":"Cancer Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming With Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma","volume":"79","author":"Galan-Cobo","year":"2019","journal-title":"Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4720.4720","article-title":"Glutaminase Inhibitor CB-839 Synergizes With Pomalidomide in Preclinical Multiple Myeloma Models","volume":"124","author":"Parlati","year":"2014","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16262","article-title":"Glutaminase Inhibitor CB-839 Synergizes With Carfilzomib in Resistant Multiple Myeloma Cells","volume":"8","author":"Thompson","year":"2017","journal-title":"Oncotarget"},{"key":"B99","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-Occurring Genomic Alterations in non-Small-Cell Lung Cancer Biology and Therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1\u2013NRF2 System in Cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3390\/cells9081766","article-title":"Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation","volume":"9","author":"Caiola","year":"2020","journal-title":"Cells"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological Roles of Mitochondrial Reactive Oxygen Species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol Cell"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.04.002","article-title":"Mitochondrial Reactive Oxygen Species Regulate Cellular Signaling and Dictate Biological Outcomes","volume":"35","author":"Hamanaka","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2017.09.026","article-title":"AMPK Maintains Cellular Metabolic Homeostasis Through Regulation of Mitochondrial Reactive Oxygen Species","volume":"21","author":"Rabinovitch","year":"2017","journal-title":"Cell Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.09.014","article-title":"AMPK-Mediated Increase of Glycolysis as an Adaptive Response to Oxidative Stress in Human Cells: Implication of the Cell Survival in Mitochondrial Diseases","volume":"1822","author":"Wu","year":"2012","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature11066","article-title":"AMPK Regulates NADPH Homeostasis to Promote Tumour Cell Survival During Energy Stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nat"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.09.019","article-title":"LKB1 Loss is Associated With Glutathione Deficiency Under Oxidative Stress and Sensitivity of Cancer Cells to Cytotoxic Drugs and \u03b3-Irradiation","volume":"156","author":"Zulato","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.041","article-title":"Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer","volume":"155","author":"Kim","year":"2013","journal-title":"Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1042\/bst0301064","article-title":"Regulation of Fatty Acid Synthesis and Oxidation by the AMP-Activated Protein Kinase","volume":"30","author":"Hardie","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1038\/s41598-019-43223-5","article-title":"A Novel Multidomain Acyl-CoA Carboxylase in Saccharopolyspora Erythraea Provides Malonyl-CoA for De Novo Fatty Acid Biosynthesis","volume":"9","author":"Livieri","year":"2019","journal-title":"Sci Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4181","article-title":"Inhibition of Acetyl-CoA Carboxylase Suppresses Fatty Acid Synthesis and Tumor Growth of Non-Small-Cell Lung Cancer in Preclinical Models","volume":"22","author":"Svensson","year":"2016","journal-title":"Nat Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.06.011","article-title":"LKB1 Inactivation Sensitizes non-Small Cell Lung Cancer to Pharmacological Aggravation of ER Stress","volume":"352","author":"Inge","year":"2014","journal-title":"Cancer Lett"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0015","article-title":"Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer","volume":"3","author":"Liu","year":"2013","journal-title":"Cancer Discovery"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00316-0","article-title":"The Hexosamine Biosynthesis Pathway is a Targetable Liability in KRAS\/LKB1 Mutant Lung Cancer","volume":"2","author":"Kim","year":"2020","journal-title":"Nat Metab"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.01.010","article-title":"The Hexosamine Biosynthetic Pathway and Cancer: Current Knowledge and Future Therapeutic Strategies","volume":"503","author":"Lam","year":"2021","journal-title":"Cancer Lett"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and One-Carbon Metabolism in Cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-21-0448","article-title":"Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-Ado","volume":"20","author":"Galan-Cobo","year":"2021","journal-title":"Mol Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.013.10086","article-title":"Dysregulation of mTOR Activity Through LKB1 Inactivation","volume":"32","author":"Zhou","year":"2013","journal-title":"Chin J Cancer"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1101\/gad.995802","article-title":"Mammalian Cell Size is Controlled by mTOR and its Downstream Targets S6K1 and 4EBP1\/Eif4e","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.42.26457","article-title":"Regulation of eIF-4e BP1 Phosphorylation by mTOR","volume":"272","author":"Hara","year":"1997","journal-title":"J Biol Chem"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0812-7","article-title":"mTOR-Targeted Cancer Therapy: Great Target But Disappointing Clinical Outcomes, Why","volume":"15","author":"Sun","year":"2021","journal-title":"Front Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbcan.2012.12.006","article-title":"Targeting LKB1 Signaling in Cancer","volume":"1835","author":"Korsse","year":"2013","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2013.06.017","article-title":"mTOR Kinase Inhibitors as Potential Cancer Therapeutic Drugs","volume":"340","author":"Sun","year":"2013","journal-title":"Cancer Lett"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.02.008","article-title":"Targeting the mTOR Kinase Domain: The Second Generation of mTOR Inhibitors","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug Discovery Today"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.12.6944","article-title":"Overcoming mTOR Inhibition-Induced Paradoxical Activation of Survival Signaling Pathways Enhances mTOR Inhibitors\u2019 Anticancer Efficacy","volume":"7","author":"Wang","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34739","article-title":"Inhibition of Mtorc1 Leads to MAPK Pathway Activation Through a PI3K-Dependent Feedback Loop in Human Cancer","volume":"118","author":"Carracedo","year":"2008","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.02.019","article-title":"The Effect of LKB1 Activity on the Sensitivity to PI3K\/mTOR Inhibition in Non\u2013Small Cell Lung Cancer","volume":"14","author":"Shukuya","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.04.026","article-title":"Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors","volume":"17","author":"Carretero","year":"2010","journal-title":"Cancer Cell"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1639","article-title":"Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma","volume":"77","author":"Kaufman","year":"2017","journal-title":"Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604886","article-title":"LKB1\/KRAS Mutant Lung Cancers Constitute a Genetic Subset of NSCLC With Increased Sensitivity to MAPK and mTOR Signalling Inhibition","volume":"100","author":"Mahoney","year":"2009","journal-title":"Br J Cancer"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1489","article-title":"Mutant LKB1 Confers Enhanced Radiosensitization in Combination With Trametinib in KRAS-Mutant Non\u2013Small Cell Lung Cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5483\/BMBRep.2019.52.1.294","article-title":"Cellular Senescence: A Promising Strategy for Cancer Therapy","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.009","article-title":"LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors","volume":"15","author":"Caiola","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1119","article-title":"First-In-Class ERK1\/2 Inhibitor Ulixertinib (BVD-523) in Patients With MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","volume":"8","author":"Sullivan","year":"2018","journal-title":"Cancer Discov"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 Protein-Serine\/Threonine Kinases in Human Cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2019.02.002","article-title":"PIK3CA in Cancer: The Past 30 Years","volume":"59","author":"Arafeh","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-021-00237-5","article-title":"Selective KRAS G12C Inhibitors in non-Small Cell Lung Cancer: Chemistry, Concurrent Pathway Alterations, and Clinical Outcomes","volume":"5","author":"Palma","year":"2021","journal-title":"NPJ Precis Onc"},{"key":"B139","article-title":"KRYSTAL-1: Updated Safety and Efficacy Data With Adagrasib (MRTX849) in NSCLC With KRASG12C Mutation From a Phase 1\/2 Study","volume":"19","author":"J\u00e4nne","year":"2020"},{"key":"B140","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.3390\/ijms22063025","article-title":"If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer","volume":"22","author":"K\u00f6hler","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1237","article-title":"An LKB1\u2013SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation","volume":"9","author":"Murray","year":"2019","journal-title":"Cancer Discov"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1261","article-title":"The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC","volume":"9","author":"Hollstein","year":"2019","journal-title":"Cancer Discov"},{"key":"B143","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41392-020-00265-w","article-title":"The Potent Roles of Salt-Inducible Kinases (SIKs) in Metabolic Homeostasis and Tumorigenesis","volume":"5","author":"Sun","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66095","article-title":"Dependency of Human and Murine LKB1-Inactivated Lung Cancer on Aberrant CRTC-CREB Activation","volume":"10","author":"Zhou","year":"2021","journal-title":"eLife"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85250","article-title":"cAMP\/CREB-Regulated LINC00473 Marks LKB1-Inactivated Lung Cancer and Mediates Tumor Growth","volume":"126","author":"Chen","year":"2016","journal-title":"J Clin Invest"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy166","article-title":"Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer","volume":"111","author":"Yang","year":"2019","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B147","doi-asserted-by":"publisher","first-page":"ra25","DOI":"10.1126\/scisignal.2000616","article-title":"New Roles for the LKB1-NUAK Pathway in Controlling Myosin Phosphatase Complexes and Cell Adhesion","volume":"3","author":"Zag\u00f3rska","year":"2010","journal-title":"Sci Signal"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2008","article-title":"LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism","volume":"89","author":"Jansen","year":"2009","journal-title":"Physiol Rev"},{"key":"B149","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal Adhesion Kinase: In Command and Control of Cell Motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.286pe55","article-title":"Tumor Suppression by LKB1: SIK-Ness Prevents Metastasis","volume":"2","author":"Shaw","year":"2009","journal-title":"Sci Signal"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.03.048","article-title":"LKB1\/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma","volume":"21","author":"Liu","year":"2012","journal-title":"Cancer Cell"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.06.021","article-title":"A Novel AMPK-Independent Signaling Pathway Downstream of the LKB1 Tumor Suppressor Controls Snail1 and Metastatic Potential","volume":"55","author":"Goodwin","year":"2014","journal-title":"Mol Cell"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.05.016","article-title":"LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis","volume":"17","author":"Slack-Davis","year":"2010","journal-title":"Cancer Cell"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.261","article-title":"Targeting LKB1 in Cancer \u2013 Exposing and Exploiting Vulnerabilities","volume":"113","author":"Momcilovic","year":"2015","journal-title":"Br J Cancer"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90487","article-title":"Targeting Adhesion Signaling in KRAS, LKB1 Mutant Lung Adenocarcinoma","volume":"2","author":"Gilbert-Ross","year":"2017","journal-title":"JCI Insight"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw6455","article-title":"The CREB Coactivator CRTC2 Promotes Oncogenesis in LKB1-Mutant non-Small Cell Lung Cancer","volume":"5","author":"Rod\u00f3n","year":"2019","journal-title":"Sci Adv"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709185104","article-title":"ID Genes Mediate Tumor Reinitiation During Breast Cancer Lung Metastasis","volume":"104","author":"Gupta","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00728-4","article-title":"LKB1 Inactivation Modulates Chromatin Accessibility to Drive Metastatic Progression","volume":"23","author":"Pierce","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1101\/gad.914401","article-title":"Cell Cycle Checkpoint Signaling Through the ATM and ATR Kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes Dev"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(00)00201-5","article-title":"DNA-PK, ATM and ATR as Sensors of DNA Damage: Variations on a Theme","volume":"13","author":"Durocher","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1042\/bj20021284","article-title":"Ionizing Radiation Induces Ataxia Telangiectasia Mutated Kinase (ATM)-Mediated Phosphorylation of LKB1\/STK11 at Thr-366","volume":"368","author":"Sapkota","year":"2002","journal-title":"Biochem J"},{"key":"B162","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molcel.2011.06.019","article-title":"ATR Autophosphorylation as a Molecular Switch for Checkpoint Activation","volume":"43","author":"Liu","year":"2011","journal-title":"Mol Cell"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3565","article-title":"WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non\u2013Small Cell Lung Cancer","volume":"77","author":"Richer","year":"2017","journal-title":"Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1511700","article-title":"Strategic Development of AZD1775, A Wee1 Kinase Inhibitor, for Cancer Therapy","volume":"27","author":"Fu","year":"2018","journal-title":"Expert Opin Investigational Drugs"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5991","article-title":"Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors","volume":"34","author":"Leijen","year":"2016","journal-title":"J Clin Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-017-0033-8","article-title":"The mTOR-S6K Pathway Links Growth Signaling to DNA Damage Response by Targeting Rnf168","volume":"20","author":"Xie","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0567","article-title":"Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma","volume":"77","author":"Liu","year":"2017","journal-title":"Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0163","article-title":"TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti\u2013PD-1 in Lung Adenocarcinoma","volume":"24","author":"Biton","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.01.003","article-title":"Mutation Patterns in a Population-Based non-Small Cell Lung Cancer Cohort and Prognostic Impact of Concomitant Mutations in KRAS and TP53 or STK11","volume":"130","author":"La Fleur","year":"2019","journal-title":"Lung Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.3384","article-title":"Molecular Determinants of Response to Anti\u2013Programmed Cell Death (PD)-1 and Anti\u2013Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non\u2013Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing","volume":"36","author":"Rizvi","year":"2018","journal-title":"JCO"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy292.033","article-title":"1411p - Identification of Genomic Markers of Sensitivity and Resistance to Checkpoint Inhibitors in Non-Small Cell Lung Cancer in a Real World Clinico-Genomic Database","volume":"29","author":"Murugesan","year":"2018","journal-title":"Ann Oncol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e15055","article-title":"Serine\/threonine Kinase 11 (STK11) Mutations and Immunotherapy Resistance in Patients With Non-Small Cell Lung Cancer","volume":"38","author":"Uba","year":"2020","journal-title":"JCO"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.3028","article-title":"Somatic STK11\/LKB1 Mutations to Confer Resistance to Immune Checkpoint Inhibitors as Monotherapy or in Combination in Advanced NSCLC","volume":"36","author":"Jure-Kunkel","year":"2018","journal-title":"JCO"},{"key":"B174","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1016\/j.jtho.2019.08.428","article-title":"OA04.07 Mutations Associated With Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis From the MYSTIC Trial","volume":"14","author":"Rizvi","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.011","article-title":"STK11\/LKB1 and KEAP1 Mutations in non-Small Cell Lung Cancer: Prognostic Rather Than Predictive","volume":"157","author":"Di Federico","year":"2021","journal-title":"Eur J Cancer"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100367","article-title":"The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism","volume":"187","author":"MacIver","year":"2011","journal-title":"JI"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939677","article-title":"LKB1 is Essential for the Proliferation of T-Cell Progenitors and Mature Peripheral T Cells","volume":"40","author":"Tam\u00e1s","year":"2009","journal-title":"Eur J Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"15876","DOI":"10.1038\/ncomms15876","article-title":"LKB1 Maintains Treg Cell Lineage Identity","volume":"8","author":"Wu","year":"2017","journal-title":"Nat Commun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3564","article-title":"Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non\u2013Small Cell Lung Cancer","volume":"81","author":"Li","year":"2021","journal-title":"Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00208-6","article-title":"ULK1 Inhibition Overcomes Compromised Antigen Presentation and Restores Antitumor Immunity in LKB1-Mutant Lung Cancer","volume":"2","author":"Deng","year":"2021","journal-title":"Nat Cancer"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1021\/cb500835z","article-title":"Structure of the Human Autophagy Initiating Kinase ULK1 in Complex With Potent Inhibitors","volume":"10","author":"Lazarus","year":"2015","journal-title":"ACS Chem Biol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0462","article-title":"The KRAS G12C Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy","volume":"20","author":"Briere","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for Lung Cancers With KRAS P.G12C Mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.889826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:42:13Z","timestamp":1652290933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.889826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":183,"alternative-id":["10.3389\/fonc.2022.889826"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.889826","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"889826"}}